World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 26 September 2016
Main ID:  NCT02242955
Date of registration: 15/09/2014
Prospective Registration: No
Primary sponsor: University Hospital, Lille
Public title: Impact of a One-month Long Detoxification Diazepam Treatment on Early Alcohol Relapse DIAMA
Scientific title: Impact of a One-month Long Detoxification Diazepam Treatment on Early Alcohol Relapse
Date of first enrolment: July 2014
Target sample size: 26
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02242955
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  N/A
Countries of recruitment
France
Contacts
Name:     Benjamin ROLLAND, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  University Hospital of Lille (CHU Lille), France
Key inclusion & exclusion criteria

Inclusion Criteria:

- DSM-IV-Tr criteria for alcohol dependence

- Diazepam-based outpatient detoxification procedure started 5 days prior to inclusion

Exclusion Criteria:

- contraindication for outpatient detoxification

- occurrence of delirium tremens or seizures during the pre-inclusion period

- contraindication for using diazepam

- any other DSM-IV-TR criteria for substance abuse or dependence in the preceding year
(except from tobacco)

- concurrent axis-I psychiatric disorder

- concurrent neurological pathology or cognitive impairment

- concurrent social risk, i.e., homelessness or social isolation

- liver failure, cancer, or significant breathing disorder



Age minimum: 18 Years
Age maximum: 60 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Alcoholism
Intervention(s)
Drug: Diazepam
Primary Outcome(s)
Rate of relapse in alcohol drinking [Time Frame: at 3 months]
Secondary Outcome(s)
Average weekly alcohol consumption [Time Frame: at 1 month; at 3 months]
Rate of relapse in heavy drinking [Time Frame: at 1 month; at 3 months]
Level of clinician-assessed anxiety [Time Frame: at 1 month; at 3 months]
Level of self-reported anxiety [Time Frame: at 1 month; at 3 months]
Level of alcohol craving [Time Frame: at 1 month; at 3 months]
Occurrence of adverse events [Time Frame: Over the first month, at 3 months]
Ratio of drinking days/heavy drinking days [Time Frame: over the first month, at 3 months]
Secondary ID(s)
2012-003336-23
2011_44
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history